Do schizophrenia and affective disorder share susceptibility genes?

Abstract:

:Schizophrenia and affective disorders are relatively common neuropsychiatric diseases with a complex genetic etiology. A multigenic inheritance with variable influence of unknown environmental factors may be involved. Family studies have demonstrated the existence of both phenotypes in the same kindreds, and in certain cases, a transition from one phenotype to another occurs. In addition, intermediate phenotypes such as schizoaffective disorders are found in families with schizophrenia and affective illness. Recent genome and chromosomal scans appear to support these epidemiologic data, since susceptibility regions for both schizophrenia and affective disorders have been found to overlap, on chromosomes 10p13-p12, 13q32, 18p and 22q11-q13. These studies were performed in independently ascertained family samples with index patients afflicted either with schizophrenia or bipolar disorder. Taken together, these findings imply shared loci for schizophrenia and affective disorders among those required for the full expression of the phenotype. Identification and molecular characterization of the genetic components conferring risk to both disorders would impact positively on diagnosis, prevention, and treatment.

journal_name

Schizophr Res

journal_title

Schizophrenia research

authors

Wildenauer DB,Schwab SG,Maier W,Detera-Wadleigh SD

doi

10.1016/s0920-9964(99)00108-5

subject

Has Abstract

pub_date

1999-09-29 00:00:00

pages

107-11; discussion 160

issue

2

eissn

0920-9964

issn

1573-2509

pii

S0920996499001085

journal_volume

39

pub_type

杂志文章,评审
  • Neurocognitive impairment across the lifespan in schizophrenia: an update.

    abstract::A literature review and power analysis of longitudinal studies published since 1997 investigating the trajectory of neurocognitive deficits across time in patients with schizophrenia was conducted. Ten studies were identified, evaluating a total of 834 patients with mean ages of 24.0-77.8 years at study entry. Power e...

    journal_title:Schizophrenia research

    pub_type: 杂志文章,评审

    doi:10.1016/j.schres.2004.07.005

    authors: Kurtz MM

    更新日期:2005-04-01 00:00:00

  • Ultrastructural evidence for glutamatergic dysregulation in schizophrenia.

    abstract::The aim of this paper is to summarize ultrastructural evidence for glutamatergic dysregulation in several linked regions in postmortem schizophrenia brain. Following a brief summary of glutamate circuitry and how synapses are identified at the electron microscopic (EM) level, we will review EM pathology in the cortex ...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2020.01.016

    authors: Roberts RC,McCollum LA,Schoonover KE,Mabry SJ,Roche JK,Lahti AC

    更新日期:2020-01-31 00:00:00

  • Early life stress and PTSD symptoms in patients with comorbid schizophrenia and substance abuse.

    abstract:OBJECTIVE:The comorbidity of schizophrenia and substance abuse is well documented and is remarkable for its prevalence and poor prognosis. While the etiology for this association is unknown, one possible mechanism relates to traumatic early life experiences, which have been shown to predispose individuals to both psych...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/s0920-9964(03)00188-9

    authors: Scheller-Gilkey G,Moynes K,Cooper I,Kant C,Miller AH

    更新日期:2004-08-01 00:00:00

  • Perception of facial emotions in chronic schizophrenia does not correlate with negative symptoms but correlates with cognitive and motor dysfunction.

    abstract:BACKGROUND:Appropriate expression of emotions and correct perception of emotional expression in others are important social skills which may be impaired in schizophrenia and contribute to poor social adjustment. We examined the relationship between expression of emotions as measured by affective flattening and other ne...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/s0920-9964(00)00093-1

    authors: Silver H,Shlomo N

    更新日期:2001-12-01 00:00:00

  • Neuropsychological functioning in early and chronic stages of schizophrenia and psychotic bipolar disorder.

    abstract:BACKGROUND:Neuropsychological impairment is common in schizophrenia and psychotic bipolar disorder. It has been hypothesized that the pathways leading to impairment differ between disorders. Cognitive impairment in schizophrenia is believed to result largely from atypical neurodevelopment, whereas bipolar disorder is i...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2018.10.009

    authors: Menkes MW,Armstrong K,Blackford JU,Heckers S,Woodward ND

    更新日期:2019-04-01 00:00:00

  • Olfactory deficits in neuroleptic naive patients with schizophrenia.

    abstract::Because previous studies have shown deficits in olfactory identification for male patients with schizophrenia, either withdrawn from or receiving neuroleptic medication, the purpose of the current study was to determine if such deficits occurred in male patients who had never received neuroleptics. A sample of male (n...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/0920-9964(93)90022-b

    authors: Kopala LC,Clark C,Hurwitz T

    更新日期:1993-01-01 00:00:00

  • N-methyl-d-aspartate-type glutamate receptor modulators and related medications for the enhancement of auditory system plasticity in schizophrenia.

    abstract::Deficits in N-methyl-d-aspartate-type (NMDAR) function contribute to cognitive deficits in schizophrenia, particularly dysfunction in neuroplasticity, defined as reduced learning during training on exercises that place implicit, increasing demands on early sensory (auditory and visual) information processing. Auditory...

    journal_title:Schizophrenia research

    pub_type: 杂志文章,评审

    doi:10.1016/j.schres.2018.02.003

    authors: Kantrowitz JT

    更新日期:2019-05-01 00:00:00

  • Dissociable contributions of MRI volume reductions of superior temporal and fusiform gyri to symptoms and neuropsychology in schizophrenia.

    abstract::We sought to identify the functional correlates of reduced magnetic resonance imaging (MRI) volumes of the superior temporal gyrus (STG) and the fusiform gyrus (FG) in patients with chronic schizophrenia. MRI volumes, positive/negative symptoms, and neuropsychological tests of facial memory and executive functioning w...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2006.11.025

    authors: Nestor PG,Onitsuka T,Gurrera RJ,Niznikiewicz M,Frumin M,Shenton ME,McCarley RW

    更新日期:2007-03-01 00:00:00

  • Computational approaches to schizophrenia: A perspective on negative symptoms.

    abstract::Schizophrenia is a heterogeneous spectrum disorder often associated with detrimental negative symptoms. In recent years, computational approaches to psychiatry have attracted growing attention. Negative symptoms have shown some overlap with general cognitive impairments and were also linked to impaired motivational pr...

    journal_title:Schizophrenia research

    pub_type: 杂志文章,评审

    doi:10.1016/j.schres.2016.10.004

    authors: Deserno L,Heinz A,Schlagenhauf F

    更新日期:2017-08-01 00:00:00

  • Relationships between depression and psychotic symptoms of schizophrenia during an acute episode and stable period.

    abstract::The aim of the present study is to explore the relationship between depression and psychotic symptoms of schizophrenia over the course of illness. Sixty-eight patients meeting DSM-IV criteria for schizophrenia were enrolled, 27 in an acute episode, 41 when stable. Assessments were performed using the Calgary Depressio...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/s0920-9964(00)00002-5

    authors: Lançon C,Auquier P,Reine G,Bernard D,Addington D

    更新日期:2001-03-01 00:00:00

  • Medium term follow-up of a randomized controlled trial of interventions for young people at ultra high risk of psychosis.

    abstract::Valid criteria to identify young people who are believed to be at ultra high risk (UHR) of developing a psychotic episode were developed over the last decade. The first randomized controlled trial of treatment in a UHR cohort indicated that specific pharmacotherapy and psychotherapy delayed onset of disorder, and poss...

    journal_title:Schizophrenia research

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.schres.2007.05.018

    authors: Phillips LJ,McGorry PD,Yuen HP,Ward J,Donovan K,Kelly D,Francey SM,Yung AR

    更新日期:2007-11-01 00:00:00

  • The Audio-Visual Abnormalities Questionnaire (AVAQ): Development and validation of a new instrument for assessing anomalies in sensory perception in schizophrenia spectrum disorders.

    abstract:BACKGROUND:Anomalies in visual and auditory perception represent an important aspect of the symptomatic manifestation of schizophrenia (ScZ). However, there are currently no instruments available that allow the assessment of the full range of auditory and visual abnormalities using a self-report measure. METHODS:We de...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2019.03.016

    authors: Nikitova N,Keane BP,Demmin D,Silverstein SM,Uhlhaas PJ

    更新日期:2019-07-01 00:00:00

  • Increased interleukin-2 serum levels were associated with psychopathological symptoms and cognitive deficits in treatment-resistant schizophrenia.

    abstract::Accumulating evidence showed that interleukin-2 (IL-2) may be involved in the pathophysiology of schizophrenia. Increased IL-2 levels have been found in the serum of schizophrenia patients with mixed results. In the present study, we assessed serum IL-2 levels in a large group of 160 schizophrenia patients compared to...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2015.10.038

    authors: Tan Y,Li Y,Tan S,Wang Z,Yang FD,Cao B,Zunta-Soares GB,Soares JC,Zhang XY

    更新日期:2015-12-01 00:00:00

  • A comprehensive genetic association and functional study of TNF in schizophrenia risk.

    abstract::In view of prior reports suggesting associations between polymorphisms of the tumor necrosis factor gene (TNF) and schizophrenia, we sequenced all exons, introns and 7 kb flanking sequence at TNF in DNA pooled from 125 Caucasian schizophrenia cases and 200 controls. We identified 18 SNPs of which we selected and genot...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2005.12.853

    authors: Shirts BH,Bamne M,Kim JJ,Talkowski M,Wood J,Yolken R,Nimgaonkar VL

    更新日期:2006-03-01 00:00:00

  • N-acetylaspartate reductions in the mediodorsal and anterior thalamus in men with schizophrenia verified by tissue volume corrected proton MRSI.

    abstract:OBJECTIVE:Deficits in the mediodorsal and anterior nuclei of the thalamus may contribute to the psychopathological symptoms of schizophrenia. These thalamic nuclei have been found to be abnormal in schizophrenia and have close connections with other brain structures implicated in the disorder. We therefore examined sch...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2005.02.012

    authors: Jakary A,Vinogradov S,Feiwell R,Deicken RF

    更新日期:2005-07-15 00:00:00

  • Developing models of how cognitive improvements change functioning: mediation, moderation and moderated mediation.

    abstract:BACKGROUND:Cognitive remediation (CRT) affects functioning but the extent and type of cognitive improvements necessary are unknown. AIM:To develop and test models of how cognitive improvement transfers to work behaviour using the data from a current service. METHOD:Participants (N49) with a support worker and a paid ...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2012.03.020

    authors: Wykes T,Reeder C,Huddy V,Taylor R,Wood H,Ghirasim N,Kontis D,Landau S

    更新日期:2012-06-01 00:00:00

  • Regional differences in expression of β-tubulin isoforms in schizophrenia.

    abstract::A growing body of evidence suggests that abnormal elements of the cytoskeleton may be associated with the pathophysiology of schizophrenia. Isoforms of a major cytoskeleton protein, β-tubulin, were recently demonstrated to have distinct roles in neuronal differentiation and cell viability. For these reasons, we tested...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2011.12.010

    authors: Moehle MS,Luduena RF,Haroutunian V,Meador-Woodruff JH,McCullumsmith RE

    更新日期:2012-03-01 00:00:00

  • Temporal associations between medication adherence for patients with schizophrenia and opioid dependence: A 17-year Canadian Cohort Study.

    abstract::The current study investigated whether a previously reported beneficial effect of methadone maintenance therapy (MMT) on antiretroviral adherence is also present in relation to antipsychotic treatment for schizophrenia. Administrative data were linked over a 17-year period for 1996 people who were dually diagnosed wit...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2019.05.031

    authors: Rezansoff SN,Moniruzzaman A,Somers JM

    更新日期:2019-08-01 00:00:00

  • Gender, psychopathology, and development: from puberty to early adulthood.

    abstract::We tested the hypothesis that the expression of schizophrenic psychopathology is dependent on the stage of adolescent development. The study had a retrospective design, using high-quality case-note material of cases of schizophrenia at first admission. Patients with onset of illness between the age of 11 and 21 years ...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/0920-9964(94)00020-9

    authors: Galdos P,van Os J

    更新日期:1995-01-01 00:00:00

  • Schizotypal dimensions: continuity between schizophrenia and bipolar disorders.

    abstract:BACKGROUND:Family studies have suggested that schizophrenia and bipolar disorders share some susceptibility factors. Schizotypal personality disorder (SPD) may be an intermediate phenotype common both to schizophrenia and bipolar disorders. We explored the familiality of schizotypal dimensions by comparing the magnitud...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2005.07.009

    authors: Schürhoff F,Laguerre A,Szöke A,Méary A,Leboyer M

    更新日期:2005-12-15 00:00:00

  • A clinical trial of the effects of estrogen in acutely psychotic women.

    abstract::This study was a preliminary open clinical trial aimed at exploring the hypothesis that estrogen may provide protection against schizophrenia in women. Eleven women with acute psychotic symptoms, as scored on the BPRS, SAPS and SANS, had 0.02 mg estradiol added to neuroleptic treatment for eight weeks. Their response ...

    journal_title:Schizophrenia research

    pub_type: 临床试验,杂志文章

    doi:10.1016/0920-9964(96)82949-5

    authors: Kulkarni J,de Castella A,Smith D,Taffe J,Keks N,Copolov D

    更新日期:1996-07-05 00:00:00

  • Negative symptoms in bipolar disorder and schizophrenia: A psychometric evaluation of the brief negative symptom scale across diagnostic categories.

    abstract::Past studies have demonstrated that the Brief Negative Symptom Scale (BNSS) has excellent psychometric properties in patients with schizophrenia. In the current study, we extended this literature by examining psychometric properties of the BNSS in outpatients diagnosed with bipolar disorder (n=46), outpatients with sc...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2015.12.014

    authors: Strauss GP,Vertinski M,Vogel SJ,Ringdahl EN,Allen DN

    更新日期:2016-02-01 00:00:00

  • Neuregulin-1 and the P300 waveform--a preliminary association study using a psychosis endophenotype.

    abstract:OBJECTIVE:Neuregulin-1 (NRG1) has been put forward as a susceptibility gene for schizophrenia. We investigated the association between Neuregulin-1 and the P300 wave, a schizophrenia endophenotype. METHODS:Participants were 64 patients with DSM-IV schizophrenia or schizoaffective disorder, 97 of their non psychotic re...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2008.03.025

    authors: Bramon E,Dempster E,Frangou S,Shaikh M,Walshe M,Filbey FM,McDonald C,Sham P,Collier DA,Murray R

    更新日期:2008-08-01 00:00:00

  • The effect of zonisamide on antipsychotic-associated weight gain in patients with schizophrenia: a randomized, double-blind, placebo-controlled clinical trial.

    abstract:BACKGROUND:Many patients with schizophrenia suffer from metabolic symptoms and weight gain in which predispose them to obesity, diabetes, and cardiovascular problems. This trial examines the efficacy and safety of zonisamide on weight and body mass index in patients with schizophrenia being administered with atypical a...

    journal_title:Schizophrenia research

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.schres.2013.03.021

    authors: Ghanizadeh A,Nikseresht MS,Sahraian A

    更新日期:2013-06-01 00:00:00

  • If patients with schizophrenia have small brains, why don't they have small heads?

    abstract::Although patients with schizophrenia have reduced brain size, there is no conclusive evidence that they have reduced head size. This begs the question: 'What is the precise relationship between head size and brain size?' We used a unique osteological collection to explore the relationship between external head measure...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/s0920-9964(99)00098-5

    authors: Friedman L,Wiechers IR,Cerny CA,Schulz SC,Buckley P

    更新日期:2000-03-16 00:00:00

  • Differences in distribution of ages of onset in males and females with schizophrenia.

    abstract::An earlier age at onset of schizophrenia in men as opposed to women, has been widely reported, but hitherto, insufficient account has been taken of parameters that might confound this finding. Furthermore, few explanatory models have accounted for the differences in shape of the age-at-onset distributions in males and...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/s0920-9964(98)00070-x

    authors: Castle D,Sham P,Murray R

    更新日期:1998-10-09 00:00:00

  • Impaired emotional learning and reduced amygdala size in schizophrenia: a 3-month follow-up.

    abstract::Individuals with schizophrenia have difficulties in emotional information processing. A relationship between behavioral variables of emotional processing and structural amygdala alterations in schizophrenia has been proposed but not shown, yet. Morphological studies of amygdala size in schizophrenia have yielded incon...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2004.02.023

    authors: Exner C,Boucsein K,Degner D,Irle E,Weniger G

    更新日期:2004-12-01 00:00:00

  • Differences in cerebellar blood volume in schizophrenia and bipolar disorder.

    abstract::Brain morphometry has been studied extensively in schizophrenic patients, and among the cortical differences identified two consistent findings are decreased cerebellar vermal volume and increased volume of the fourth ventricle; although contradictory findings are reported as well. Recent cognitive activation studies ...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/s0920-9964(98)00137-6

    authors: Loeber RT,Sherwood AR,Renshaw PF,Cohen BM,Yurgelun-Todd DA

    更新日期:1999-05-04 00:00:00

  • Psychological well-being and mental health recovery in the NIMH RAISE early treatment program.

    abstract::Recovery-oriented practices that promote client-centered care, collaboration, and functional outcome have been recommended to improve treatment engagement, especially for individuals with serious mental illness (SMI). Psychological well-being (PWB) is related to recovery and refers to experiencing purpose and meaning ...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2016.11.032

    authors: Browne J,Penn DL,Meyer-Kalos PS,Mueser KT,Estroff SE,Brunette MF,Correll CU,Robinson J,Rosenheck RA,Schooler N,Robinson DG,Addington J,Marcy P,Kane JM

    更新日期:2017-07-01 00:00:00

  • Insulin secretion in patients receiving clozapine, olanzapine, quetiapine and risperidone.

    abstract:BACKGROUND:Second-generation antipsychotics (SGAs) increase the risk of type 2 diabetes. The mechanism is thought to center on drug-induced weight gain, which starts the dysmetabolic cascade of insulin resistance, increased insulin production and pancreatic beta-cell failure. An independent effect of SGAs on insulin se...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2012.11.016

    authors: Manu P,Correll CU,Wampers M,van Winkel R,Yu W,Shiffeldrim D,Kane JM,De Hert M

    更新日期:2013-02-01 00:00:00